A Food and Drug Administration panel of health experts convened Wednesday to discuss and promote the health benefits of testosterone treatments for men. FDA Commissioner Martin Makary told Morning ...
A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
On November 26, Truist analyst William Stein increased the price target for Analog Devices, Inc. (NASDAQ:ADI) from $249 to $258 and kept a Hold rating on the stock. The analyst noted in the research ...
ProMed, a contract manufacturer specializing in liquid silicone rubber (LSR) and highly regulated combination products, has announced new process refinements in the LSR injection molding process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback